Buys
Open market- Shares
- Avg price
- Total value
Joseph K. Belanoff - Chief Executive Officer, Director at CORCEPT THERAPEUTICS INC
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- CORT on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Joseph K. Belanoff in CORCEPT THERAPEUTICS INC
Sells
Open market- Shares
- -239,035
- Avg price
- $69.48
- Total value
- -$16,609,139
Net
Past year- Shares
- -239,035
- Share %
- -100%
- Total value
- -$16,609,139
Reported holdings for Joseph K. Belanoff in CORCEPT THERAPEUTICS INC
Form 4 holding
Chief Executive Officer, Director
CORCEPT THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 2,565,489
- Estimated value
- $178,917,202
- Report date
- 01 Jun 2026
- Price
- $69.74
- Ownership
- Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
Form 4 holding
Chief Executive Officer, Director
CORCEPT THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 150,000
- Estimated value
- $6,046,500
- Report date
- 29 May 2026
- Price
- $40.31
- Ownership
- Joseph K. Belanoff 2026 Grantor Retained Annuity Trust
Form 4 holding
Chief Executive Officer, Director
CORCEPT THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 150,000
- Estimated value
- $6,046,500
- Report date
- 29 May 2026
- Price
- $40.31
- Ownership
- Katherine A. Blenko 2026 Grantor Retained Annuity Trust
Form 4 holding
Chief Executive Officer, Director
CORCEPT THERAPEUTICS INC
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 24 Dec 2025
- Price
- $77.29
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
CORCEPT THERAPEUTICS INC
- Security class
- Stock Option (right to buy)
- Shares / value
- 460,000
- Estimated value
- Report date
- 27 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Joseph K. Belanoff in CORCEPT THERAPEUTICS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.